AMTI Applied Molecular Transport Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AMTI

Price (delayed)

$0.3936

Market cap

$15.43M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.25

Enterprise value

-$10.51M

Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, ...

Highlights
Applied Molecular Transport's debt has decreased by 9% YoY
The net income has contracted by 26% YoY but it has grown by 6% from the previous quarter
AMTI's EPS is down by 22% year-on-year but it is up by 6% since the previous quarter
The company's quick ratio has shrunk by 64% YoY and by 25% QoQ
Applied Molecular Transport's equity has plunged by 63% YoY and by 22% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Peers: OVID

Key stats

What are the main financial stats of AMTI
Market
Shares outstanding
39.2M
Market cap
$15.43M
Enterprise value
-$10.51M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.25
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$126.33M
EBITDA
-$114.9M
Free cash flow
-$98.05M
Per share
EPS
-$3.25
Free cash flow per share
-$2.52
Book value per share
$1.56
Revenue per share
$0
TBVPS
$2.77
Balance sheet
Total assets
$107.45M
Total liabilities
$46.61M
Debt
$36.12M
Equity
$60.84M
Working capital
$48.93M
Liquidity
Debt to equity
0.59
Current ratio
4.24
Quick ratio
4.11
Net debt/EBITDA
0.23
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-90.1%
Return on equity
-138.5%
Return on invested capital
-178.4%
Return on capital employed
-136.8%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMTI stock price

How has the Applied Molecular Transport stock price performed over time
Intraday
0.15%
1 week
6.38%
1 month
-39.34%
1 year
-94.83%
YTD
-6.29%
QTD
-6.29%

Financial performance

How have Applied Molecular Transport's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$127.22M
Net income
-$126.33M
Gross margin
N/A
Net margin
N/A
The net income has contracted by 26% YoY but it has grown by 6% from the previous quarter
Applied Molecular Transport's operating income has decreased by 26% YoY but it has increased by 6% from the previous quarter

Growth

What is Applied Molecular Transport's growth rate over time

Valuation

What is Applied Molecular Transport stock price valuation
P/E
N/A
P/B
0.25
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
AMTI's EPS is down by 22% year-on-year but it is up by 6% since the previous quarter
AMTI's P/B is 75% below its last 4 quarters average of 1.0
Applied Molecular Transport's equity has plunged by 63% YoY and by 22% from the previous quarter

Efficiency

How efficient is Applied Molecular Transport business performance
The ROE has plunged by 132% YoY and by 21% from the previous quarter
Applied Molecular Transport's ROA has plunged by 73% YoY and by 12% from the previous quarter
The return on invested capital has declined by 33% year-on-year

Dividends

What is AMTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMTI.

Financial health

How did Applied Molecular Transport financials performed over time
The company's total assets is 131% higher than its total liabilities
The company's quick ratio has shrunk by 64% YoY and by 25% QoQ
The current ratio has shrunk by 64% YoY and by 25% QoQ
Applied Molecular Transport's debt is 41% less than its equity
The debt to equity has surged by 146% year-on-year and by 26% since the previous quarter
Applied Molecular Transport's equity has plunged by 63% YoY and by 22% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.